Corient Private Wealth
IART icon

Corient Private Wealth’s Integra LifeSciences IART Stock Holding History

Corient Private Wealth’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$409K Buy
22,749
+9,120
+67% +$128K ﹤0.01% 2370
2026
Q1 		$128K Sell
13,629
-1,559
-10% -$17.1K ﹤0.01% 2645
2025
Q4 		$189K Buy
+15,188
New +$202K ﹤0.01% 2443
2023
Q2 		– Sell
-7,723
Closed -$443K – 2116
2023
Q1 		$443K Buy
+7,723
New +$435K ﹤0.01% 1437

Other funds holding IART

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Corient Private Wealth's IART Position: Q2 2026 in Review

Corient Private Wealth increased its Integra LifeSciences (IART) stake by 67% in Q2 2026, buying an estimated $128K and bringing the position to 22,749 shares worth $409K. The position accounts for ﹤0.01% of the portfolio, ranked #2370.

Corient Private Wealth first reported a position in IART in Q1 2023 and has held it in 4 quarters since. The position peaked at $443K in Q1 2023. 212 funds tracked by Wall St. Rank hold IART as of Q2 2026.

  • Corient Private Wealth held 22,749 shares of Integra LifeSciences worth $409K as of Q2 2026.
  • Corient Private Wealth bought 9,120 Integra LifeSciences shares in Q2 2026, an estimated $128K.
  • Integra LifeSciences made up ﹤0.01% of Corient Private Wealth's portfolio in Q2 2026, its #2370 holding.
  • Corient Private Wealth first reported a position in Integra LifeSciences in Q1 2023 and has held it in 4 quarters since.
  • Corient Private Wealth's Integra LifeSciences position peaked at $443K in Q1 2023.
  • 212 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.